These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9712784)

  • 21. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
    Martinez LR; Moussai D; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3674-9. PubMed ID: 15155683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D; Kozel TR
    Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.
    Vecchiarelli A; Pietrella D; Bistoni F; Kozel TR; Casadevall A
    Immunology; 2002 Jun; 106(2):267-72. PubMed ID: 12047756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
    Cleare W; Casadevall A
    Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells.
    Ellerbroek PM; Hoepelman AI; Wolbers F; Zwaginga JJ; Coenjaerts FE
    Infect Immun; 2002 Sep; 70(9):4762-71. PubMed ID: 12183517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal capsular glucuronoxylomannan reduces ischaemia-related neutrophil influx.
    Ellerbroek PM; Schoemaker RG; van Veghel R; Hoepelman AI; Coenjaerts FE
    Eur J Clin Invest; 2004 Sep; 34(9):631-40. PubMed ID: 15379763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.
    Chiapello LS; Baronetti JL; Aoki MP; Gea S; Rubinstein H; Masih DT
    Immunology; 2004 Nov; 113(3):392-400. PubMed ID: 15500627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of cytokine expression in mice immunized with cryptococcal polysaccharide, a glucuronoxylomannan (GXM), associated with peritoneal antigen-presenting cells (APC): requirements for GXM, APC activation, and interleukin-12.
    Blackstock R; McElwee N; Neller E; Shaddix-White J
    Infect Immun; 2000 Sep; 68(9):5146-53. PubMed ID: 10948138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.
    Vecchiarelli A; Retini C; Monari C; Tascini C; Bistoni F; Kozel TR
    Infect Immun; 1996 Jul; 64(7):2846-9. PubMed ID: 8698522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
    Maitta RW; Datta K; Lees A; Belouski SS; Pirofski LA
    Infect Immun; 2004 Jan; 72(1):196-208. PubMed ID: 14688097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
    Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
    J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
    Fleuridor R; Lees A; Pirofski L
    J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophils.
    Rocha JD; Nascimento MT; Decote-Ricardo D; Côrte-Real S; Morrot A; Heise N; Nunes MP; Previato JO; Mendonça-Previato L; DosReis GA; Saraiva EM; Freire-de-Lima CG
    Sci Rep; 2015 Jan; 5():8008. PubMed ID: 25620354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
    Deshaw M; Pirofski LA
    Clin Exp Immunol; 1995 Mar; 99(3):425-32. PubMed ID: 7882565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the complement anaphylatoxins in the recruitment of eosinophils.
    DiScipio RG; Schraufstatter IU
    Int Immunopharmacol; 2007 Dec; 7(14):1909-23. PubMed ID: 18039528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.
    Sundstrom JB; Cherniak R
    Infect Immun; 1993 Apr; 61(4):1340-5. PubMed ID: 8095924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation.
    Vecchiarelli A; Pietrella D; Lupo P; Bistoni F; McFadden DC; Casadevall A
    J Leukoc Biol; 2003 Sep; 74(3):370-8. PubMed ID: 12949240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunoregulation by capsular components of Cryptococcus neoformans.
    Vecchiarelli A
    Med Mycol; 2000 Dec; 38(6):407-17. PubMed ID: 11204878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.